Corcept Therapeutics
CORT
#2302
Rank
A$11.85 B
Marketcap
A$108.37
Share price
3.10%
Change (1 day)
-6.66%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): A$10.22 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.83 Billion. In 2025 the company made an earning of A$64.7 Million a decrease over its 2024 earnings that were of A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$10.22 M-84.19%
2025 A$64.7 M-67.29%
2024 A$0.19 B27.66%
2023 A$0.15 B-4.75%
2022 A$0.16 B-9.51%
2021 A$0.17 B-2.91%
2020 A$0.18 B14.87%
2019 A$0.16 B24.71%
2018 A$0.12 B69.32%
2017 A$76.34 M419.26%
2016 A$14.7 M-395.64%
2015 -A$4.98 Million-87.53%
2014 -A$39.9 Million-33.44%
2013 -A$59.94 Million
2011 -A$46.71 Million17.84%
2010 -A$39.64 Million35.5%
2009 -A$29.25 Million2.84%
2008 -A$28.44 Million60.81%
2007 -A$17.69 Million-52.14%
2006 -A$36.96 Million20.91%
2005 -A$30.57 Million31.87%
2004 -A$23.18 Million60.54%
2003 -A$14.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.04 B 292,187.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.26 B 197,292.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.97 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.22 B 542,744.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.10 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.36 B 176,824.28%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$70.28 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.21 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA